A theoretical study of chemical delivery within the lung using exogenous surfactant

Medical Engineering and Physics

Volumn 25, Issue 2, 2003, Pages 115-132

  Zhang, Yong Liang ^a   Matar, Omar K ^a   Craster, Richard V ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Airway liquid; Drug therapy; Gene therapy; Modelling; Respiratory distress syndrome; Surfactant therapy

Indexed keywords

ABSORPTION; DIFFUSION; MATHEMATICAL MODELS; PATIENT TREATMENT; PULMONARY DISEASES; SURFACE ACTIVE AGENTS; VISCOSITY OF LIQUIDS;

CHEMICAL DELIVERY;

BIOMEDICAL ENGINEERING;

LUNG SURFACTANT;

ADULT; AIRFLOW; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA VECTOR; DOSE RESPONSE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; FLOW RATE; GENE TARGETING; GENE THERAPY; HUMAN; LUNG DIFFUSION; LUNG INJURY; MATHEMATICAL MODEL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; VISCOSITY;

EID: 0037344691     PISSN: 13504533     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-4533(02)00190-X     Document Type: Article

References (61)

1. Kharasch V.S., Sweeney T.D., Fredberg J., Lehr J., Damokosh A.I., Avery M.E., Brain J.D. Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am Rev Respir Dis. 144:1991;909-913.
2. van Daal G.J., Bos J.A.H., Eijking E.P., Gommers D., Hannappel E., Lachmann B.S. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am Rev Respir Dis. 145:1992;859-863.
3. Lachmann B., Gommers D. Is it rational to treat pneumonia with exogenous surfactant? Eur Respir J. 6:1993;1437-1438.
4. Palta M., Sadek M., Barnet J.H., Evans M., Weinstein M.R., McGuinness G., Peters M.E., Gabbert D., Fryback D., Farrell P. Evaluation of criteria for chronic lung disease in surveying very low birth weight infants. J Pediatr. 132:1998;57-63.
5. Liechty E.A., Donovan E., Purohit D., Gilhooly J., Feldman B., Noguchi A., Denson S.E., Sehgal S.S., Gross I., Stevens D., Ikegami M., Zachman R.D., Carrier S.T., Gunkel J.H., Gold A.J. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birthweight neonates with respiratory distress syndrome. Pediatrics. 88:1991;19-28.
6. Weinberger B., Weiss K., Heck D.E., Laskin D.L., Laskin J.D. Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Therap. 89:2001;67-97.
7. Zgleeszewski S.E., Cilley R.E., Krummel T.M., Chinoy M.R. Effects of dexamethasone, growth factors and tracheal ligation on the development of nitrogen-exposed hypoplastic murine fetal lungs in organ culture. J Pediatr Surg. 34:1999;1187-1195.
8. Seymour J.F., Presneill J.J., Schoch O.D., Downie G.H., Moore P.E., Doyle I.R., Vincent J.M., Nakata K., Kitamura T., Langton D., Pain M.C., Dunn A.R. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med. 163:2001;524-531.
9. Albelda S.M., Wiewrodt R., Zuckerman J.B. Gene therapy for lung disease: hype or hope? Ann Intern Med. 132:2000;649-660.
10. Robertson B., Taeusch H.W. Postscript: perspectives for the future. Robertson B., Taeusch H.W. Surfactant therapy for lung disease. 84:1995;Marcel Dekker Inc, New York.
11. Manuel S.M., Guo Y., Matalon S.E. Exosurf enhances adenoviras-mediated gene transfer to alveolar type II cells. Am. J. Physiol. 273:1997;L741-L748.
12. Katkin J.P., Husser R.C., Langston C., Welty S.E. Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum Gene Ther. 8:1997;171-176.
13. Nievescruz B., Rivera A., Cifuentes J., Patki G., Matalon S., Carlo W.A., Tanswell A.K., Freeman B. Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. Am J Physiol-Lung Cell Mol Physiol. 14:1996;L657-L667.
14. Jobe A.H., Ueda T., Whitsett J.A., Trapnell B.C., Ikegami M. Surfactant enhances advenovirus mediated gene expression in rabbit lungs. Gene Ther. 3:1996;775-779.
15. Konishi M., Fujiwara T., Naito T., Takeuchi Y., Ogawa Y., Inukai K., Fujimura M., Nakamura H., Hashimoto T. Surfactant replacement therapy in neonatal respiratory distress syndrome, a multi-centre, randomized clinical trial: comparison of high- versus low dose surfactant TA. Eur J Pediatr. 147:1988;20-25.
16. Salathe M., O'Riordan T.G., Wanner A. Mucociliary clearance. Crystal R.G., West J.B., Barnes P.J., Weibel E.R. The lung: scientific foundations. 1997;2295-2308 Lippincott-Raven, Philadelphia, PA.
17. Jensen O.E., Grotberg J.B. The spreading of heat or soluble surfactant along a thin film. Phys Fluids A. 5:1993;58-68.
18. Espinosa F.F., Kamm R.D. Bolus dispersal through the lungs in surfactant replacement therapy. J Appl Physiol. 86:1999;391-410.
19. Niven R.W., Whitcomb K.L., Shaner L., Ip A.Y., Kinstler O.B. The pulmonary absorption of aerosolized and intratracheally instilled RHG-CSF and monopegylated RHG-CSF. Pharm Res. 12:1995;1343-1349.
20. Gao X., Wientjes M.G., An J.L.S. Extensive absorption of 2′,3′-dideoxyinosine by intratracheal administration in rates. Pharm Res. 12:1995;1901-1906.
21. 10 studies. Phil Trans R Soc Lond A. 358:2000;2707-2718.
22. Marques H.M.C., Hadgraft J., Kellaway I.W., Taylor G. Studies of cyclodextrin inclusion complexes. 3. The pulmonary absorption of β-cyclodextrin, dm-β-cyclodextrin and hp-β-cyclodextrin in rabbits. Int J Pharm. 77:1991;297-302.
23. Jani P.U., Mccarthy D.E., Florence A.T. Nanosphere and microsphere uptake via Peyer patches - observation of the rate of uptake in the rat after a single oral dose. Int J Pharm. 86:1992;239-246.
24. Bruderman I., Somerrs K., Hamilton W.K., et al. Effect of surface tension on circulation in the excised lungs of dogs. J Appl Physiol. 19:1964;707-712.
25. 99mTc-DTPA in infants who subsequently develop bronchopulmonary dysplasia. Am Rev Respir Dis. 137:1988;210-212.
26. Jensen O.E., Halpern D., Grotberg J.B. Transport of a passive solute by surfactant-driven flows. Chem Engng Sci. 49:1994;1107-1117.
27. Gaver III D.P., Grotberg J.B. The dynamics of a localized surfactant on a thin film. J. Fluid Mech. 213:1990;127-148.
28. Halpern D., Grotberg J.B. Dynamics and transport of a localized soluble surfactant on a thin film. J. Fluid Mech. 237:1992;1-11.
29. Espinosa F.F., Kamm R.D. Thin layer flows due to surface tension gradients on a membrane undergoing non-uniform, periodic strain. Ann Biomed Engng. 25:1997;913-925.
30. Halpern D., Jensen O.E., Grotberg J.B. A theoretical study of the surfactant and liquid delivery into the lung. J Appl Physiol. 85:1998;333-352.
31. Grotberg J.B., Halpern D., Jensen O.E. Interaction of exogenous and endogenous surfactant: spreading rate effects. J Appl Physiol. 78:1995;750-756.
32. Weibel E.R., Gomez D.M. Architecture of the human lung. Science Wash. DC. 137:1962;577.
33. Halpern D., Grotberg J.B. Surfactant effects on fluid-elastic instabilities of liquid-lined flexible tubes - a model of airway-closure. J Biomech Engng. 85:1993;333-352.
34. Kamm R.D., Schroter R.C. Is airway closure caused by a thin liquid instability? Respir Physiol. 75:1989;141-156.
35. Espinosa F.F., Kamm R.D. Meniscus formation during tracheal instillation of surfactant. J Appl Physiol. 85:1998;266-272.
36. Cassidy K.J., Bull J.L., Glucksberg M.R., Dawson C.A., Haworth S.T., Hirschl R., Gavriely N., Grotberg J.B. A rat lung model of instilled liquid transport in the pulmonary airways. J Appl Physiol. 90:2001;1955-1967.
37. Fairbrother F., Stubbs A.E. Studies in electroendosmosis. J Chem Soc Lond. 1:1935;527-529.
38. Wanner A. Effects of methlxanthines on airway mucociliary function. Am J Med. 79:1985;16-21.
39. Cassidy K.J., Halpern D., Ressler B.G., Grotberg J.B. Surfactant effects in model airway closure experiments. J Appl Physiol. 87:1999;415-427.
40. Keast P., Muir P.H. Algorithm 688 EPDCOL - a more efficient PDECOL Code. ACM Trans Math Software. 17:1991;153-166.
41. Craster R.V., Matar O.K. Surfactant transport on mucus films. J Fluid Mech. 425:2000;235-258.
42. Gortner L. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung. 168:1990;864-869.
43. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Eur J Pediatr. 150:1991;433-439.
44. Sakata E.K., Berg J.C. Surface diffusion in monolayers. Ind Eng Chem Fundam. 8:1969;570-575.
45. 99mTc-tobramycin using pulmonary surfactant as vehicle. Br J Pharm. 126:1999;1091-1096.
46. Cussler E.L. Diffusion: mass transfer in fluid systems. 1984;Cambridge University Press, Cambridge.
47. Banerjee R., Bellare J.R., Puniyani R.R. Effect of phospholipid mixtures and surfactant formulations on rheology of polymeric gels, simulating mucus, at shear rates experienced in the tracheobronchial tree. Biochem Engng J. 7:2001;195-200.
48. Jensen O.E., Grotberg J.B. Insoluble surfactant spreading on a thin viscous film: shock evolution and film rupture. J Fluid Mech. 240:1992;259-288.
49. Gaver III D.P., Grotberg J.B. Droplet speading on a thin viscous film. J Fluid Mech. 235:1992;399-414.
50. Hislop A., Muir D.C.F., Jacobsen M., Simon G., Reid L. Postnatal growth and function of the pre-acinar airways. Thorax. 27:1972;265-274.
51. Zola E.M., Gunkel J.H., Chan R.K., Lim M.O., Knox I., Feldman B.H., Denson S.E., Stonestreet B.S., Mitchell B.R., Wyza M.M., Bennett K.J., Gold A.J. Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr. 122:1993;453-459.
52. Udea T., Ikegami M., Rider E.D., Jobe A.H. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol. 76:1994;45-55.
53. Halliday H.L., Tarnow-Mordi W.O., Corcoran J.D., et al. Multicentre randomized trial comparing high and low dose surfactant regimes for the treatment of respiratory distress syndrome (The Curosurf 4 Trial). Arch Dis Child. 69:1993;276-280.
54. Banerjee R., Puniyani R.R. Exogeneous surfactant therapy and mucus rheology in chronic obstructive airway diseases. J Biomat Appl. 14:2000;243-272.
55. Duchateau G.S.M.J.E., Zuidema J., Merkusf F.W.H.M. Bile salts and intranasal absorption. Int J Pharm. 31:1986;193-199.
56. Wollmer P., Backstrom K., Zhao H., Nilsson P.G., Jonson B. Surface active agents as enhancers of alveolar absorption. Pharm Res. 17:2000;38-41.
57. van't Veen A., Mouton J.W., Gommers D., Lachmann B. Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br J Pharmacol. 119:1996;1145-1148.
58. Mathieu M., Gougat C., Jaffuel D., Danielsen M., Godard P., Bousequet J., Demoly P. The glucocorticoid receptor gene as a candidate for gene therapy in asthma. Gene Ther. 6:1999;245-252.
59. Haitsma J.J., Lachmann U., Lachmann B. Exogenous surfactant as a drug delivery agent. Adv Drug Delivery Rev. 47:2001;197-207.
60. 99mTc-tobramycin in pneumonia: effect of pulmonary surfactant as vehicle. Am J Resp Crit Care Med. 155:1997;A108.
61. Zhang Y.L., Matar O.K., Craster R.V. Surfactant spreading on a thin weakly viscoelastic film. J Non-Newtonian Fluid Mech. 105:2002;53-78.